LIST OF CLINICAL TRIALS THAT ARE CURRENTLY RECRUITING PARTICIPANTS

Updated as of July 31, 2017

For studies that are active but not recruiting participants, please contact the Clinical Research Center. This list does not include studies under the Cellular Therapeutics Center.


Acute Venous Thromboembolism
Characterization of patients following acute venous thromboembolism (VTE) and assessment of safety and effectiveness of dabigatran etexilate (DE) in the treatment and secondary prevention of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) in comparison to vitamin K antagonist (VKA) in routine clinical practice

Principal Investigator:   Dr. Mary Milagros Uy    

Learn More

Diabetes Mellitus 
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents with Type 2 Diabetes

Principal Investigator:    Dr. Sylvia Capistrano-Estrada


Learn More


Liver Cancer
Phase 1 Dose Escalation Trial to evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Reximmune-C2 (HSV-Thymidine Kinase-m2 and hGM-CSF Genes) in Refractory patients with primary Hepatocellular Carcinoma or Tumors Metastatic to the Liver

Principal Investigator:   Dr. Ma. Belen M. Tamayo
Co-Investigator:              Dr. Regina Edusma-Dy
 

Lung Cancer
A Randomised, Parallel, Double Blinded Study to Compare the Efficacy and Safety of FKB238 to Avastin® In 1st Line Treatment for Patients with Advanced/Recurrent Non-Squamous Non-Small Cell Lung Cancer in Combination of Paclitaxel and Carboplatin
 
Principal Investigator:   Dr. Ma. Belen M. Tamayo
Co-Investigator:              Dr. Joseph D. Parra


Learn More


Phase 3 Open-label, Multicentre, Randomised Trial to Establish Safety & Efficacy of an EGF Cancer Vaccine in Inoperable, Stage IV Biomarker Positive,Wild Type EGF-R NSCLC Patients Eligible to Receive Standard Treatment and Supportive Care

Principal Investigator:   Dr. Ma. Belen M. Tamayo
Co-Investigator:              Dr. Regina Edusma-Dy

Learn More


A Randomized, Open Label, Phase III Study of Overall Survival Comparing Pembrolizumab (MK-3475) Versus Platinum Based Chemotherapy in Treatment Naïve Subjects With PD-L1 Positive Advanced or Metastatic Non-Small Cell Lung Cancer (Keynote 042)

Principal Investigator:   Dr. Ma. Belen M. Tamayo
Co-Investigator:              Dr. Joseph D. Parra

Learn More
 

Open Angle Glaucoma
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients with Open-angle Glaucoma or Ocular Hypertension

Principal Investigator:   Dr. Benjamin M. Abela, Jr
Co-Investigator:              Dr. Ma. Zita Meriales

Learn More
 

Pancreatic Cancer
A Phase III, Open-label, Randomized Study of the Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Patients With Locally Advanced or Metastatic Pancreatic Cancer

Principal Investigator:   Dr. Ma. Belen M. Tamayo
Co-Investigator:              Dr. Regina Edusma-Dy

Learn More